High cholesterol can absolutely be genetic. The most well-known inherited form, familial hypercholesterolemia (FH), affects roughly 1 in 313 people worldwide and causes dangerously elevated LDL cholesterol from birth. But genetics influence cholesterol levels on a spectrum: some people carry a single powerful gene mutation, others inherit dozens of smaller genetic variants that collectively push their numbers up, and many more have cholesterol shaped by a mix of genes and lifestyle. Understanding where you fall on that spectrum matters because it changes your risk and how aggressively you need to manage it.
How Genetics Raise Cholesterol
Your body clears LDL (often called “bad” cholesterol) from the bloodstream using receptors on liver cells. In the most direct genetic form, a mutation in one of three genes disrupts this cleanup process. The most common mutations affect the LDL receptor itself, but mutations in two other genes (APOB and PCSK9) can have a similar effect. The result is the same: LDL particles accumulate in the blood because the liver can’t pull them out efficiently. This process begins at birth and continues for life, meaning cholesterol builds up in artery walls years or decades earlier than it would from diet alone.
This single-gene form is what doctors call monogenic FH. But there’s also a polygenic version, where no single mutation is responsible. Instead, hundreds of small genetic variations each nudge LDL levels slightly higher. Researchers have identified at least 223 such variants that contribute to a person’s polygenic cholesterol score. Two people can have the same LDL number on a blood test, but the one whose cholesterol is driven by a monogenic mutation faces higher cardiovascular risk than the one with polygenic or lifestyle-driven causes. That distinction is one reason genetic testing has become more common in cholesterol management.
LDL Levels That Suggest a Genetic Cause
The CDC identifies an LDL level above 190 mg/dL in adults as one of the main signs of FH. In children, the threshold is lower: above 160 mg/dL. These numbers refer to untreated levels, meaning what your cholesterol is without medication. If your LDL has always run well above 190 despite a reasonable diet, genetics is a likely contributor.
In more severe cases, untreated LDL can climb above 250 or even 325 mg/dL. People who inherit a mutation from both parents (homozygous FH) can have LDL levels above 500 mg/dL, though this is extremely rare. Many people with the heterozygous form, inheriting a mutation from one parent, walk around with LDL in the 190 to 300 range for years without knowing they have a genetic condition, especially if they’re otherwise healthy and active.
Physical Signs to Watch For
Most people with genetically high cholesterol have no visible symptoms, which is why it often goes undiagnosed. But some develop telltale physical signs that point strongly toward FH.
Xanthomas are yellowish, waxy bumps caused by cholesterol deposits under the skin. They tend to appear on tendons, particularly the Achilles tendon, and on the elbows, knees, and hands. Xanthelasmas are similar deposits that form around the eyelids. A corneal arcus, a white, grey, or blue ring around the colored part of the eye, can also signal FH when it appears before age 45. In the diagnostic scoring system doctors use, tendon xanthomas alone carry enough weight to make a diagnosis highly likely.
The Cardiovascular Stakes
The reason genetic high cholesterol gets so much clinical attention is the cardiovascular risk it carries. Untreated FH increases the lifetime risk of coronary heart disease by roughly 20-fold compared to the general population. Because elevated LDL starts at birth rather than developing gradually in middle age, artery damage accumulates much earlier.
The numbers are stark. Among untreated men with FH, about 50% will have a heart attack or other serious coronary event by age 50. For untreated women, the figure is 30% by age 60. These aren’t risks that develop slowly in old age. They hit during what should be the most productive decades of life, which is why early identification changes outcomes so dramatically. People diagnosed and treated in childhood or early adulthood can bring their risk much closer to normal.
How Genetic High Cholesterol Is Diagnosed
Doctors use a combination of blood work, family history, physical exam findings, and sometimes genetic testing to make a diagnosis. The most widely used framework is the Dutch Lipid Clinic Network criteria, which assigns points across several categories. A score above 8 points means a definite diagnosis, 6 to 8 is probable, and 3 to 5 is possible.
Points come from multiple sources. An untreated LDL above 325 mg/dL scores 8 points on its own. Having a first-degree relative (parent, sibling, or child) who developed heart disease before age 55 for men or 60 for women adds points. Physical signs like tendon xanthomas score 6 points, and a corneal arcus before age 45 scores 4. A confirmed genetic mutation in one of the three known genes scores 8 points and is considered definitive.
Genetic testing isn’t always necessary for a diagnosis, but it offers clarity in borderline cases. It’s also valuable for another reason: once a mutation is identified in one family member, it becomes a precise tool for screening relatives.
Screening Your Family
When one person is diagnosed with FH, doctors recommend cascade screening, a systematic process of testing relatives. It starts with first-degree family members: parents, siblings, and children. If an affected parent is identified, screening expands to that entire side of the family, including cousins. Each new case found through this process becomes the starting point for screening their own relatives.
Cascade screening can be done with a simple cholesterol blood test, genetic analysis, or both. Genetic testing improves accuracy significantly. About 20% of family members who carry an FH mutation have only modestly elevated LDL that wouldn’t raise red flags on a standard blood test. Without genetic confirmation, those cases get missed. If you have a parent or sibling diagnosed with FH, getting screened yourself is one of the most straightforward steps you can take.
When to Start Testing Children
Children with a family history of early heart disease or known FH can be screened for high cholesterol as early as age 2. Lipid screening can be performed at any age once a high-risk condition is identified in the family. For FH specifically, early detection is especially valuable because treatment during childhood prevents decades of arterial cholesterol buildup. An LDL above 160 mg/dL in a child with a family history is a strong signal.
Treatment for Genetic High Cholesterol
Lifestyle changes like diet and exercise matter for everyone with high cholesterol, but they’re rarely enough on their own when genetics are the primary driver. Someone whose liver receptors are genetically impaired at clearing LDL will still have high levels even on an ideal diet. Medication is almost always part of the plan.
Statins remain the foundation of treatment and are typically started early. For people who don’t reach their target LDL on statins alone, a newer class of injectable medications called PCSK9 inhibitors can make a substantial difference. In clinical trials involving FH patients, PCSK9 inhibitors reduced LDL by an average of 49%, with some studies showing reductions of 57% to 62%. These medications work by blocking a protein that normally degrades LDL receptors on liver cells, essentially helping the liver do the job that the genetic mutation impairs.
The goal of treatment is to lower LDL early enough and aggressively enough to prevent the cardiovascular events that untreated FH so reliably causes. People with FH who start treatment in their 20s face a very different outlook than those diagnosed after their first heart attack at 45. That gap between early and late treatment is why awareness of genetic cholesterol matters as much as the treatment itself.